SCHEMBL7150732

SCHEMBL7150732

CC(=O)Oc1ccc(N2C(=O)c3ccccc3C2=O)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GLA P06280 1/20 0.61
KMT2A Q03164 5/20 0.60
MEN1 O00255 3/20 0.60
NPC1 O15118 1/20 0.60
TLR9 Q9NR96 1/20 0.60
SCN2A Q99250 2/20 0.58
NPSR1 Q6W5P4 2/20 0.56
CA9 Q16790 2/20 0.56
CA12 O43570 1/20 0.56
CA1 P00915 1/20 0.56
CA2 P00918 1/20 0.56
NR1H3 Q13133 1/20 0.55
L3MBTL1 Q9Y468 1/20 0.54
HSD17B10 Q99714 3/20 0.53
POLB P06746 1/20 0.53
KDM4E B2RXH2 1/20 0.52
PPARD Q03181 1/20 0.52
PPARA Q07869 1/20 0.52
LMNA P02545 2/20 0.52
ALDH1A1 P00352 2/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11537116 0.87 HSD17B10 (0.61) GLAKMT2AMEN1NPC1TLR9
SCHEMBL10796884 0.86 KMT2A (0.63) GLAKMT2AMEN1NPC1TLR9
SCHEMBL10601959 0.84 HSD17B10 (0.73) KMT2AMEN1NPC1TLR9HSD17B10
SCHEMBL19411347 0.82 HSD17B10 (0.53) GLAKMT2AMEN1NPC1TLR9
SCHEMBL9516311 0.81 HSD17B10 (0.77) KMT2AMEN1SCN2ANPSR1CA9
SCHEMBL27264218 0.80 KMT2A (0.53) KMT2AMEN1SCN2ACA9CA12
SCHEMBL14877657 0.80 MEN1 (0.52) GLAKMT2AMEN1NPC1TLR9
SCHEMBL2550387 0.79 NR1H3 (0.81) KMT2AMEN1NPC1SCN2ANR1H3
SCHEMBL3408445 0.78 KMT2A (0.66) KMT2AMEN1SCN2ACA9CA12
SCHEMBL14877640 0.78 HSD17B10 (0.58) GLAKMT2AMEN1NPC1TLR9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1076644-B1 N-SUBSTITUTED AMINOTETRALINS AS LIGANDS FOR THE NEUROPEPTIDE Y Y5 RECEPTOR USEFUL IN THE TREATMENT OF OBESITY AND OTHER DISORDERS ORTHO MCNEIL PHARM INC (US) 2004-06-23 EP disclosed
EP-1076644-A1 N-SUBSTITUTED AMINOTETRALINS AS LIGANDS FOR THE NEUROPEPTIDE Y Y5 RECEPTOR USEFUL IN THE TREATMENT OF OBESITY AND OTHER DISORDERS Ortho-McNeil Pharmaceutical, Inc. (US) 2001-02-21 EP disclosed
US-6140354-A FOR TREATMENT OF DISORDERS OR DISEASE STATES CAUSED BY EATING DISORDERS, OBESITY, BULIMIA NERVOSA, DIABETES, HYPERTENSION, MEMORY LOSS, EPILEPTIC SEIZURES, MIGRAINE, SLEEP DISTURBANCES, PAIN, SEXUAL/REPRODUCTIVE DISORDERS, DEPRESSION ORTHO-MCNEIL PHARMACEUTICAL, INC. (US) 2000-10-31 US disclosed
WO-1999055667-A1 N-SUBSTITUTED AMINOTETRALINS AS LIGANDS FOR THE NEUROPEPTIDE Y Y5 RECEPTOR USEFUL IN THE TREATMENT OF OBESITY AND OTHER DISORDERS ORTHO-MCNEIL PHARMACEUTICAL, INC. (US) 1999-11-04 WO disclosed
EP-0161413-B1 WHOLLY AROMATIC POLYESTERS, PROCESS FOR THEIR PREPARATION AND SHAPED ARTICLES MADE THEREFROM HOECHST AKTIENGESELLSCHAFT (DE) 1989-01-18 EP disclosed
US-4661579-A Completely aromatic polyesters, a process for their preparation and corresponding shaped articles HOECHST AKTIENGESELLSCHAFT (DE) 1987-04-28 US disclosed
EP-0161413-A1 Wholly aromatic polyesters, process for their preparation and shaped articles made therefrom HOECHST AKTIENGESELLSCHAFT (DE) 1985-11-21 EP disclosed